Discover
TOI
The Oncology Institute, Inc.
5.51
2 x 4.03
2 x 6.86
bid
ask
+
0.08
1.47%
2 @ 05:50 AM
5.64 +0.13 (2.36%)
| Ytd | 54.78% | |
| 1y | 150.45% |
5.36
day range
5.62
2.19
52 week range
5.82
| Open | 5.36 | Prev Close | 5.43 | Low | 5.36 | High | 5.62 | Mkt Cap | 550.91M |
| Vol | 1.54M | Avg Vol | 1.71M | EPS | -0.35 | P/E | N/A | Forward P/E | -1.28 |
| Beta | 0.62 | Short Ratio | 3.38 | Inst. Own | 47.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 4.46 | 200-d Avg | 3.65 | 1yr Est | 2.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-13 | 2024-09 | 0 | -0.18 | N/A | N/A |
| 2024-08-13 | 2024-06 | -0.1 | -0.17 | -0.07 | -70.00% |
| 2024-05-14 | 2024-03 | -0.12 | -0.22 | -0.1 | -83.33% |
| 2024-03-27 | 2023-12 | -0.11 | -0.21 | -0.1 | -90.91% |
| 2023-11-08 | 2023-09 | -0.13 | -0.19 | -0.06 | -46.15% |
| 2023-08-08 | 2023-06 | -0.17 | -0.19 | -0.02 | -11.76% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2023-06-16 | Guggenheim | Upgrade | Buy | |
| 2023-03-20 | Guggenheim | Upgrade | Neutral | |
| 2022-11-11 | Guggenheim | Upgrade | Buy | |
| 2022-08-15 | Jefferies | Upgrade | Buy |
Profile
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-11-21 | BARASCH RICHARD A | Director | 417.19K | Stock Award(Grant) |
| 2024-12-01 | HIVELY BRAD | Director | 666.75K | Purchase |
| 2024-11-21 | JOHNSON KAREN MARIE | Director | 167.19K | Stock Award(Grant) |
| 2024-11-21 | KAUSHAL MOHIT | Director | 177.25K | Stock Award(Grant) |
| 2024-11-21 | LING GABRIEL | Director | 109.06K | Stock Award(Grant) |
| 2024-11-21 | MCGEORGE ANNE | Director | 183.35K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | FMR, LLC | 4.75M | 969.45K | 6.29% |
| 2024-09-29 | Deerfield Management Company, L.P. (Series C) | 3.36M | 685.79K | 4.45% |
| 2024-09-29 | TIFF Advisory Services, Inc. | 2.63M | 537.37K | 3.48% |
| 2024-09-29 | Cincinnati Insurance Company | 2.03M | 415.15K | 2.69% |
| 2024-09-29 | Kent Lake PR LLC | 2.00M | 408.20K | 2.65% |
| 2024-09-29 | Vanguard Group Inc | 1.78M | 364.00K | 2.36% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Growth Company Fund | 1.80M | 367.27K | 2.38% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 1.27M | 259.90K | 1.69% |
| 2024-10-30 | Fidelity Growth Company K6 Fund | 431.19K | 88.01K | 0.57% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 422.98K | 86.33K | 0.56% |
| 2024-10-30 | Fidelity Series Growth Company Fund | 377.38K | 77.02K | 0.50% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 192.24K | 39.24K | 0.25% |